Skip to main content

Articles

Recent Articles

Top considerations for developing a biomarker solution and CDx strategy
Articles  —  7 December Dec 2023

Top considerations for developing a biomarker solution and CDx strategy

Read More about Top considerations for developing a biomarker solution and CDx strategy
Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Articles  —  6 December Dec 2023

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Read More about Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Articles  —  6 December Dec 2023

Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay

Read More about Antibody Reagent Spotlight – Generating positive control antibodies for your Anti-Drug Antibody (ADA) assay
Antibody reagents for your host cell protein assay: Experience counts
Articles  —  6 December Dec 2023

Antibody reagents for your host cell protein assay: Experience counts

Read More about Antibody reagents for your host cell protein assay: Experience counts
Antibody reagents for your host cell protein assay: Experience counts
Articles  —  6 December Dec 2023

Antibody reagents for your host cell protein assay: Experience counts

Read More about Antibody reagents for your host cell protein assay: Experience counts
Antibody Critical Reagents: Challenges and Risks in Their Lifecycle Management
Articles  —  6 December Dec 2023

Antibody Critical Reagents: Challenges and Risks in Their Lifecycle Management

Read More about Antibody Critical Reagents: Challenges and Risks in Their Lifecycle Management
Antibody Critical Reagents: Challenges and Risks in Their Lifecycle Management
Articles  —  6 December Dec 2023

Antibody Critical Reagents: Challenges and Risks in Their Lifecycle Management

Read More about Antibody Critical Reagents: Challenges and Risks in Their Lifecycle Management
Nomenclature Change from NASH/NAFLD to MASH/MASLD
Articles  —  6 December Dec 2023

Nomenclature Change from NASH/NAFLD to MASH/MASLD

Read More about Nomenclature Change from NASH/NAFLD to MASH/MASLD
COVID-19 Now: Accessing the Latest Vaccines
Articles  —  6 December Dec 2023

COVID-19 Now: Accessing the Latest Vaccines

Read More about COVID-19 Now: Accessing the Latest Vaccines
Pancreatic Cancer: Overview and Promising New Therapies
Articles  —  6 December Dec 2023

Pancreatic Cancer: Overview and Promising New Therapies

Read More about Pancreatic Cancer: Overview and Promising New Therapies
Nomenclature Change from NASH/NAFLD to MASH/MASLD
Articles  —  6 December Dec 2023

Nomenclature Change from NASH/NAFLD to MASH/MASLD

Read More about Nomenclature Change from NASH/NAFLD to MASH/MASLD
COVID-19 Now: Accessing the Latest Vaccines
Articles  —  6 December Dec 2023

COVID-19 Now: Accessing the Latest Vaccines

Read More about COVID-19 Now: Accessing the Latest Vaccines